Bristol-Myers Squibb

Bristol-Myers CEO Giovanni Caforio nets $18.7M in 2017 pay, a 10% raise
Fierce Pharma
Wed, 03/28/18 - 07:13 pm
Bristol-Myers Squibb
Pharma CEOs
Giovanni Caforio
executive pay
Bristol-Myers' Opdivo-Yervoy combo scores again at FDA, this time in colorectal cancer
Fierce Pharma
Tue, 03/27/18 - 09:56 pm
Bristol-Myers Squibb
Opdivo
Yervoy
FDA
colorectal cancer
Lawsuit Claims Drug Abilify Causes Compulsive Gambling
Legal Scoops
Mon, 03/19/18 - 11:37 pm
Abilify
gambling
compulsive behavior
Bristol-Myers Squibb
Otsuka
Why A Biopharma Buying Spree May Target AstraZeneca, Bristol
Investors Business Daily
Sat, 03/17/18 - 09:57 am
AstraZeneca
Bristol-Myers Squibb
Vertex Pharmaceuticals
M&A
[video]How Convenience Can Give Drugmakers a Competitive Edge
Motley Fool
Tue, 03/13/18 - 10:08 am
convenience
Merck
Bristol-Myers Squibb
dosing
Opdivo
Keytruda
FDA approves new dosing for Bristol-Myers Squibb's Opdivo
Yahoo/Reuters
Tue, 03/6/18 - 09:46 am
FDA
Bristol-Myers Squibb
Opdivo
dosing
cancer
melanoma
Bristol losing its I/O talent to the likes of Pfizer, report finds
Biopharma Dive
Sat, 02/24/18 - 10:39 pm
Bristol-Myers Squibb
Pfizer
Celgene
immuno-oncology
R&D
3 Big Drugmakers Boosting Huge R&D Budgets
Motley Fool
Sat, 02/24/18 - 11:23 am
R&D
Bristol-Myers Squibb
Celgene
JNJ
If Pfizer is itching to make a major deal, Bristol-Myers Squibb is probably on its radar screen
Motley Fool
Thu, 02/22/18 - 11:14 am
Pfizer
M&A
Bristol-Myers Squibb
Bristol-Myers axes 107 more staffers as it completes an R&D overhaul
Endpoints
Thu, 02/22/18 - 11:10 am
Bristol-Myers Squibb
layoffs
R&D
Connecticut
Can Bristol-Myers Squibb Squeeze $3.6 Billion From Its Nektar Therapeutics Deal?
Motley Fool
Tue, 02/20/18 - 09:47 am
Bristol-Myers Squibb
M&A
Nektar Therapeutics
Bristol-Myers To Pay Largest Fee In Biotech History For Nektar Cancer Drug
Forbes
Wed, 02/14/18 - 11:51 am
Bristol-Myers Squibb
Nektar Therapeutics
NKTR-214
cancer
More Questions Than Answers For Bristol-Myers
Forbes
Tue, 02/6/18 - 09:18 am
Bristol-Myers Squibb
Opdivo
Yervoy
Bristol claims victory in crucial immunotherapy trial, but results raise some questions
Stat
Mon, 02/5/18 - 11:52 am
Bristol-Myers Squibb
Opdivo
Yervoy
advanced lung cancer
Bristol-Myers surges 5.6% on advanced lung cancer trial results, Q4 earnings
Marketwatch
Mon, 02/5/18 - 08:33 am
Bristol-Myers Squibb
earnings
Opdivo
Yervoy
advanced lung cancer
How Bristol-Myers and Pfizer are using real-world data to unseat warfarin
Biopharma Dive
Mon, 01/29/18 - 11:59 pm
Bristol-Myers Squibb
Pfizer
Warfarin
real world evidence
RWE
bloodthinners
Eliquis
Bristol-Myers calls on real-world evidence to unseat warfarin
Biopharma Dive
Wed, 01/24/18 - 08:15 pm
Bristol-Myers Squibb
Warfarin
Eliquis
Pfizer
bloodthinners
Opdivo-Yervoy combo 'encouraging' in colorectal cancer
Biopharma Dive
Mon, 01/22/18 - 10:54 am
Opdivo
Yervoy
Bristol-Myers Squibb
colorectal cancer
Whom Will Pfizer Buy in 2018?
Motley Fool
Mon, 01/22/18 - 09:42 am
Pfizer
M&A
Biogen
Bristol-Myers Squibb
Allergan
5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them
Motley Fool
Sun, 01/21/18 - 10:53 am
Merck
Keytruda
AbbVie
Humira
Mavyret
Bristol-Myers Squibb
Eliquis
Pfizer
Ibrance

Pages